cancer patients� lives at risk due to savage tory nhs cuts causing delays to treatment by 18 months.
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.